Replies to post #202464 on Biotech Values

[DewDiligence]

NVS confirms planned CTL019 BLA in early 2017, which means they will be the first CAR-T company to file for regulatory approval in a major jurisdiction; these are the CTL019 data in r/rALL from ASH:

http://finance.yahoo.com/news/novartis-presents-results-first-global-000700117.html